Skip to content

Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02966444
Enrollment
16
Registered
2016-11-17
Start date
2016-10-31
Completion date
2018-07-31
Last updated
2018-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight Changes

Brief summary

This study evaluates the effects of dietary fatty acid composition from high fat meals on markers of hunger, satiety and metabolism.

Interventions

OTHERMUFA-rich HF Meal
OTHERPUFA-rich HF Meal
OTHERSFA-rich HF Meal

Sponsors

Texas Christian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI of \>18.5-24.9kg/m2 * Woman * 18-40yrs of age

Exclusion criteria

* Evidence of weight loss or gain exceeding 5% of their body weight within the past 3 months. * Plans to lose weight or begin a weight loss program between initiation of study and final testing. * Plans to begin an exercise program or change current exercise routines between initiation of study and final testing. * Is on a medically prescribed diet * Does not consume breakfast regularly * Rate less than 80% of foods offered in the buffet at 50mm or more on the 100mm VAS as palatable * Medications that could influence appetite or sensory function * Reports of metabolic or endocrine disease, gastrointestinal disorders, or history of medical or surgical events that could affect fat digestion and hormone signaling. * Any chronic disease including type II diabetes, hypothyroidism, hyperthyroidism, cardiovascular disease, and cancer * Any supplements that a subject begins taking between initiation of study and final testing. * Anyone who is currently pregnant, lactating, or planning on becoming pregnant before the conclusion of this study. * Anyone who has allergies to any of the components of the liquid meals * Anyone who has donated blood in the last 20 days

Design outcomes

Primary

MeasureTime frame
Peptide-YY18 months

Secondary

MeasureTime frame
Visual Analog Scale18 months

Countries

United States

Contacts

Primary ContactJada L Stevenson, PhD
jada.stevenson@tcu.edu817-257-6310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026